Market announcement: voluntary suspension

21 October 2022

Mr James Gerraty
Adviser, Listings Compliance (Melbourne)
Australian Securities Exchange
Level 4, North Tower, Rialto
525 Collins Street
Melbourne VIC 3000

By email

Dear James

Medibank Private Limited – request for voluntary suspension

Due to the expiry of the maximum period to be in trading halt, Medibank Private Limited (Medibank) requests a voluntary suspension in respect of its shares (ASX code: MPL).

For the purposes of ASX Listing Rule 17.2, Medibank provides the following information:

• Whilst there is currently no further information to provide to the market following the announcement dated Thursday 20 October 2022, Medibank is seeking voluntary suspension of its shares to enable it to manage its continuous disclosure and provide an update to the market on the status and implications of the cyber incident announced on Thursday 13 October 2022 in accordance with its obligations under listing rule 3.1;
• Medibank requests that the voluntary suspension continues until the earlier of a release of a further announcement by Medibank and commencement of normal trading on Wednesday 26 October 2022;
• Medibank is not aware of any reason its shares should not be voluntarily suspended; and
• Medibank is not aware of any other information necessary to inform the market about the voluntary suspension.

Should you require any further information, please do not hesitate to contact me.

Yours sincerely,

Mei Ramsay Company Secretary